Literature DB >> 21598221

Diabetic ketoacidosis and its complications among children.

Afshin Safaei Asl1, Shohreh Maleknejad, Morteza Ebrahimi Kelachaye.   

Abstract

In order to recognize of DKA and its complications among children with DM type I, we conducted a descriptive study and all of the children with the final diagnosis of DKA. Data regarding their demographics, disease characteristics, treatment features and outcome derived from patients' medical files and registered in a data sheet. Data were analyzed using SPSS 11.0 and exhibited in the form of frequency tables and charts. There were 33 females and 30 males (53.1% and 46.9%, respectively). They were involved with ketoacidosis most commonly in summer (42.2%). Autumn, winter and spring seasons were in the next turns (29.7%, 15.6%, and 12.5%, respectively). Data analysis showed a clear improvement in the time taken to correct the acidosis with respect to the date of admission (more than 40 hours in the initial year to less than 28 hours at the final year). It seems that the management of diabetic ketoacidosis has improved during recent years. We concluded to consider ketoacidosis even in the first admission of a diabetic child.

Entities:  

Mesh:

Year:  2011        PMID: 21598221

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  3 in total

Review 1.  Risk factors for mortality in children with diabetic keto acidosis from developing countries.

Authors:  Varadarajan Poovazhagi
Journal:  World J Diabetes       Date:  2014-12-15

2.  The relationship between hyperchloremia and acute kidney injury in pediatric diabetic ketoacidosis and its impact on clinical outcomes.

Authors:  Heba Mostafa Ahmed; Hagar Ramadan Hasb Elnaby; Rehab Muhammad Abd El Kareem; Mahmoud Hodeib
Journal:  Pediatr Nephrol       Date:  2021-11-05       Impact factor: 3.651

3.  Spectrum of complications of severe DKA in children in pediatric Intensive Care Unit.

Authors:  Qalab Abbas; Saba Arbab; Anwar Ul Haque; Khadija Nuzhat Humayun
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.